Wixela vs Xopenex
What to choose Wixela or Xopenex
Wixela is inhaler of type Control while Xopenex is of Rescue type. Wixela and Xopenex are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Xopenex is manufactured by Sunovion. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Xopenex is Levalbuterol. The available dosage for Xopenex is 45 mcg.
The actual cost for Wixela is roughly $240 per inhaler while current price for Xopenex is approximately $256 per inhaler, said Everett Smith, a Lecturer at the University of Notre Dame and a Physician at a clinic that uses Wixela and Xopenex.
Wixela and Xopenex Comparison
| Wixela | Xopenex | |
|---|---|---|
| Type: | Control | Rescue |
| Manufacturer: | Viatris | Sunovion |
| Substance: | Fluticasone + Salmeterol | Levalbuterol |
| Dosage: | 250/50 | 45 mcg |
| Avg Price: | $240 | $256 |